PSPC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.648200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.127200E-01
Normal-vs-Stage2
3.567000E-01
Normal-vs-Stage3
2.337600E-01
Normal-vs-Stage4
7.696800E-01
Stage1-vs-Stage2
2.865400E-01
Stage1-vs-Stage3
4.285700E-02
Stage1-vs-Stage4
1.947380E-01
Stage2-vs-Stage3
1.677030E-01
Stage2-vs-Stage4
1.043350E-01
Stage3-vs-Stage4
3.293600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.881800E-01
Normal-vs-AfricanAmerican
5.551600E-01
Normal-vs-Asian
4.648600E-01
Caucasian-vs-AfricanAmerican
8.746000E-01
Caucasian-vs-Asian
8.228800E-01
AfricanAmerican-vs-Asian
9.937000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.132000E-01
Normal-vs-Female
4.274200E-01
Male-vs-Female
5.715000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.759600E-01
Normal-vs-Age(41-60Yrs)
5.526600E-01
Normal-vs-Age(61-80Yrs)
4.517400E-01
Normal-vs-Age(81-100Yrs)
5.873000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.738200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.706000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.959240E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.632030E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.049400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.468400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.187000E-01
Normal-vs-Daily Drinker
4.099200E-01
Normal-vs-Weekly Drinker
1.685830E-01
Normal-vs-Occasional Drinker
9.083800E-01
Normal-vs-Social Drinker
4.578600E-01
Non Drinker-vs-Daily Drinker
3.657200E-01
Non Drinker-vs-Weekly Drinker
7.022200E-01
Non Drinker-vs-Occasional Drinker
1.283510E-02
Non Drinker-vs-Social Drinker
2.086400E-01
Daily Drinker-vs-Weekly Drinker
2.546000E-01
Daily Drinker-vs-Occasional Drinker
9.454500E-02
Daily Drinker-vs-Social Drinker
6.947800E-01
Weekly Drinker-vs-Occasional Drinker
2.174400E-02
Weekly Drinker-vs-Social Drinker
1.174450E-01
Occasional Drinker-vs-Social Drinker
1.779050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.132400E-02
Normal-vs-Grade 2
9.991000E-04
Normal-vs-Grade 3
3.078100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.799800E-01
Grade 1-vs-Grade 3
5.492600E-01
Grade 1-vs-Grade 4
8.132400E-02
Grade 2-vs-Grade 3
8.805200E-01
Grade 2-vs-Grade 4
9.991000E-04
Grade 3-vs-Grade 4
3.078100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.556000E-01
Normal-vs-NonDiabetic
4.985600E-01
Diabetic-vs-NonDiabetic
1.939830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.616780E-01
Normal-vs-NoPancreatitis
4.653000E-01
Pancreatitis-vs-NoPancreatitis
1.765840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.844400E-01
Normal-vs-N1
3.394800E-01
N0-vs-N1
4.496400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.576600E-01
Normal-vs-TP53-NonMutant
7.673600E-01
TP53-Mutant-vs-TP53-NonMutant
4.778200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
